Accelerate to discover

Back to filter

Related topics

Hypoxia in the Tumor Immune Microenvironment (TIME)

Bruker Biospin

Jun 6, 2024

Thursday, 11 July 2024, 16:00 CET | 10:00 EST
Zaver M. Bhujwalla, PhD...

Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics

Spectral Instruments Imaging

Jun 3, 2024

Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM
...

Have you missed any recent Cytek webinars? Watch webinars and product tutorial videos at any time

Cytek Biosciences

Apr 23, 2024

Have you missed any recent Cytek webinars? Watch webinars and product tutorial videos at any time at Cytek website....

Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic

Bruker Biospin

Apr 2, 2024

25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical
...

Jun 18, 2024

Multiplexed tissue imaging using the Orion platform to reveal the Spatial Biology of Cancer

RareCyte

Mar 27, 2024

In this webinar Prof. Sandro Santagata, will reveal how Orion high-plex imaging and the use of this data, is valuable...

Improve your data resolution with Cytek Autofluorescence Extraction tool!

Cytek Biosciences

Feb 5, 2024

Samples with high autofluorescence (AF) can be difficult to resolve with conventional flow cytometry, especially if...

Webinar: transforming Calcium Flux analysis with Cytek Full Spectrum Profiling Technology

Cytek Biosciences

Jan 4, 2024

The research described in this webinar harnesses the innovative capabilities of FSP technology to perform advanced...

Jun 18, 2024

Webinar recording: BioFlux, the gold standard for Platelet Biology and Vascular Pharmacology studies

Cell Microsystems

Jan 3, 2024

The BioFlux system give you the ability to introduce physiological shear flow to your research and drug discovery...

Show all topics (10)

Monitoring cancer treatments with immuno-PET webinar

Mar 8, 2019

The clinical use of full-length mAbs as imaging agents can be challenging, due to their long biological half-life and relatively slow tumor penetration, which may affect tumor-to-background contrast at early time points. To circumvent these issues, Dr Gabriela Kramer-Marek’s team has developed radiolabeled affibody-based PET tracers that still have high specificity and affinity of the potential therapeutic mAb, but their molecular weight below 60 kDa allows for rapid renal clearance and elimination. In this webinar, Dr Gabriela Kramer-Marek will focus on HER-specific imaging radioconjugates that could provide unique information as cancer biomarkers, including quantification of receptor heterogeneity and early detection of changes in target expression in response to therapy.

Dr Ali Asgar Attarwala, Bruker BioSpin and Dr Gabriela Kramer-Marek, Team Leader Preclinical Molecular Imaging, The Institute of Cancer Research London 

Register Now

Webinar

Related technologies: PET, SPECT, CT

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 210 323 421

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Albira combines PET, SPECT and CT imaging in a unique and extremely powerful way

show detail

High Performance Total Body PET and CT for mice & rats with fast scan times with unparalleled quality

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey